Our Blog

03 Jun

Starpharma signs second oncology agreement with AstraZeneca

By Finance News

03 Jun 2019 – Starpharma (ASX:SPL) has today announced a Development and Option Agreement with AstraZeneca to progress the development (of a Dendrimer Enhanced Product (DEP) version )of an undisclosed AstraZeneca major marketed oncology medicine.


Source: Finance News Network

Share this post

Related Posts

14 Nov

Opthea completes patient recruitment ahead of schedule in Phase 2b Wet AMD clinical trial

14 Nov 2018 - Biotech company, Opthea (ASX:OPT) has announced that recruitment into the... read more

04 Jul

Market within 100 points of an all-time high: ASX 0.6% higher at noon

04 Jul 2019 - The ASX is around 100 points away at noon from... read more

18 Jan

CIMIC Group’s UGL in new $200m contracts

18 Jan 2019 - CIMIC Group (ASX:CIM) company UGL has secured contract extensions to... read more

17 Sep

Boart Longyear announces majority stake in GlobalTech Corporation

17 Sep 2018 - Boart Longyear (ASX:BLY) is to become a majority stake holder... read more

10 Oct

Navitas offered a buyout from a consortium

10 Oct 2018 - Education company Navitas (ASX:NVT) has received an buyout offer from... read more

27 Jul

Friday photo Finish: Aus shares 0.9% higher at noon

27 Jul 2018 - Market at Midday. Best rally all week, most sectors up... read more

12 Oct

Strong finish: Aus shares closes 0.39 higher

12 Oct 2017 - Market Wrap. read more

22 Feb

Mayne Pharma Group posts 35% increase in underlying half year profit

22 Feb 2019 - Pharmaceutical company Mayne Pharma Group (ASX:MYX) released their half year... read more

27 Aug

Pilbara Minerals finalises terms sheet with POSCO for South Korean JV

27 Aug 2019 - Lithium producer, Pilbara Minerals (ASX:PLS) has finalised and executed a... read more

07 Jun

Cashless payments are the future: Gary Hamel

07 May 2019 - World leading business strategist, Gary Hamel, says mobile payments are... read more